Sanofi Signs US$2.54 B Collaboration Deal with Skyhawk Therapeutics for RNA-splicing Modulators
By Ashish Tripathi
Pharma Deals Review: Vol 2022 Issue 7 (Table of Contents)
Published: 14 Jul-2022
DOI: 10.3833/pdr.v2022.i7.2705 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In a bid to bolster its pipeline, Sanofi has partnered with Skyhawk Therapeutics to discover, develop, and commercialise small molecule therapeutics for immunology and oncology targets...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS